
ELV News
Elevance Health Inc.
$390.16
-$10.68(-2.66%)
71
Overall
100
Value
63
Tech
50
Quality
Market Cap
$84.30B
Volume
2.73M
52W Range
$274.84 - $450.69
Target Price
$478.71
ELV news: the latest Elevance Health Inc. headlines, press releases and market updates, newest first.
Latest ELV News
- Bernstein Reaffirms Their Buy Rating on Elevance Health (ELV)TipRanks Auto-Generated Intelligence Newsdesk · Nov 19, 2026
- Elevra Lithium Reports All Resolutions Carried at 2026 AGMTipRanks Australian Auto-Generated Newsdesk · Nov 19, 2026
- Elevra Lithium Reports FY2026 Merger Integration and Portfolio FocusTipRanks Australian Auto-Generated Newsdesk · Nov 18, 2026
- Elevra Lithium Reports FY2026 Merger Integration and Portfolio FocusTipRanks Australian Auto-Generated Newsdesk · Nov 18, 2026
- Healthcare Stocks: UnitedHealth (UNH), Humana (HUM), Cigna (CI) and Others Fall on Proposed CRUSH RuleWilliam White · Nov 18, 2026
- Healthcare Stocks: UnitedHealth (UNH), Humana (HUM), Cigna (CI) and Others Fall on Proposed CRUSH RuleWilliam White · Nov 18, 2026
- Elevra Lithium Reports Director Lucas Dow’s 26,525-Share PurchaseTipRanks Auto-Generated Newsdesk · Nov 16, 2026
- EvoNext Makes Ascend’s Audited 2025/26 Statements AvailableTipRanks Switzerland Auto-Generated Newsdesk · Nov 16, 2026
- EvoNext Publishes EGM Invitation for Ascend CombinationTipRanks Switzerland Auto-Generated Newsdesk · Nov 12, 2026
- Guerbet Reports Share Capital and Voting Rights FiguresTipRanks European Auto-Generated Newsdesk · Nov 10, 2026
- Selva Gida Consolidated Interim Financial Statements Cover Period Ended September 30, 2026TipRanks Turkey Auto-Generated Newsdesk · Nov 9, 2026
- Selva Gıda’s Consolidated Operating Review Covers January–September 2026TipRanks Turkey Auto-Generated Newsdesk · Nov 9, 2026
- Selva Gida Board Approves January–September 2026 Summarized Financial StatementsTipRanks Turkey Auto-Generated Newsdesk · Nov 9, 2026
- Enliven Therapeutics (ELVN) Gets a Buy from Stifel NicolausTipRanks Auto-Generated Intelligence Newsdesk · Nov 5, 2026
- EvoNext Publishes Ascend Financial Statements Ahead of MergerTipRanks Switzerland Auto-Generated Newsdesk · Nov 5, 2026
- Elevra Lithium Reports Lucas Dow’s Share and Rights ChangesTipRanks Auto-Generated Newsdesk · Nov 4, 2026
- Elevra Lithium Announces Brisbane AGM Venue Name ChangeTipRanks Australian Auto-Generated Newsdesk · Nov 1, 2026
- Elevra Lithium Finalizes US$71 Million Sale of Ghana Ewoyaa Project to HuayouTipRanks Auto-Generated Newsdesk · Oct 30, 2026
- UBS Keeps Their Buy Rating on Elevra Lithium (SYAXF)TipRanks Auto-Generated Intelligence Newsdesk · Oct 29, 2026
- Elevra Lithium Delivers Record Quarter and Deepens North American FocusTipRanks Australian Auto-Generated Newsdesk · Oct 26, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ELV | $390.16 | -2.7% | 2.73M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |